ArticleAmerican journal of cancer research2023

A novel 4-1BB/HER2 bispecific antibody shows potent antitumor activities by increasing and activating tumor-infiltrating T cells.

Aolin Shen et al.PubMed ↗Full text ↗

No numbers read from the abstract.